NIPH Clinical Trials Search

Basic Information

Recruitment status	recruiting
Health condition(s) or Problem(s) studied	Crohn's disease
Date of first enrollment	11/10/2018
Target sample size	200
Countries of recruitment
Study type	Observational
Intervention(s)	investigational material(s) Generic name etc : Budesonide ( Zentacort Capsules 3mg ) INN of investigational material : Budesonide Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Adverse event, clinical laboratory tests, efficacy
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	mild to moderate active Crohn's disease in patients
Exclude criteria